Fetal and Neonatal Monitoring Devices Market
Fetal and Neonatal Monitoring Devices Market is segmented By Monitoring Devices (Fetal Monitoring Devices, Neonatal Monitoring Devices), By Portability (Portable Monitoring Devices, Non-Portable Monitoring Devices), By End-User (Hospitals, Neonatal Care Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030.
Fetal and Neonatal Monitoring Devices Market is expected to grow at a CAGR of 6.8% during the forecasting period (2023-2030). The neonatal period is one of the most vulnerable periods for a child’s health. According to World Health Organization (WHO), 340,000 maternal deaths, 2.7 million stillbirths, and 3.1 million neonatal deaths occur worldwide each year. Fetal and neonatal critical care equipment are medical devices using which doctors can continuously monitor, evaluate and treat diseases in the prenatal and postnatal stages of infants. These devices are used to feed the babies medicine, fluids, or even draw blood, check the blood pressure, treat a number of diseases, and continuously monitor the status and health of the baby.
According to United Nations International Children and Emergency Funds (UNICEF), around 15 million babies are born preterm every year. Some of the reasons for preterm birth are the rise in maternal age and changes in lifestyle such as smoking, drinking, and obesity. Maternal & infant care is a global priority, as around 800 women die every day due to pregnancy or childbirth.
Fetal and Neonatal Monitoring Devices Market Scope
Metrics |
Details |
Market CAGR |
6.8% |
Segments Covered |
By Monitoring Devices, By Portability, By End-User, and By Region |
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
Regions Analyzed |
North America, Latin America, Europe, Middle East, Africa, Asia Pacific, and the Rest of the world. |
Major Companies Covered |
FzioMed, Inc., Amniox Medical, Inc., Human Regenerative Technologies, LLC, Amnio Technology, LLC, Derma Sciences, MiMedx Group, Inc, and among other major companies listed in the full report |
To know more insights into the Market, Get Our Sample Brochure
Market Dynamics
The major drivers driving the market are rising cases of preterm birth due to premature rupture of the membrane, increase in maternal age, change in lifestyles such as drinking and smoking, and technological advancements.
According to the Centre for Disease Control and Prevention (CDC), the mean age of mothers at the time of first birth has increased from 24.9 years in 2000 to 27 years in 2018. Older mothers are more prone to chronic diseases and the babies are more susceptible to genetic disorders like Downs Syndrome. Furthermore, according to a study conducted by the National Institute of Alcohol Abuse and Alcoholism in 2017, 86.4% of people aged 18 or older reported that they drank alcohol at some point in their lifetime, out of which 42% are women. Alcoholism leads to preterm birth and Fetal Alcohol Syndrome, which causes brain damage and growth problems and can’t be cured.
Damage to fetal and maternal tissues, as well as trauma, pain, and in some cases, miscarriage due to invasive approach and strict regulatory procedures for the new products are going to restrain the market in the forecast period.
Segmentation Analysis
The global fetal and neonatal monitoring devices market is segmented by monitoring devices as fetal and neonatal. Fetal devices are further segmented as Heart Rate Monitors, Uterine Contraction monitors, Pulse Oximeters, and Others. Neonatal is further segmented into Cardiac Monitors, Capnography, Blood Pressure Monitors, Pulse Oximeters, Respiratory Monitoring Devices, and Others. By portability as portable and non-portable and by end-users as hospitals and neonatal care centers.
Fetal devices are expected to dominate the market over the period of forecast with a share of more than 60%, as new technological advances like wireless fetal monitors, integrated fetal monitors, and electronic fetal monitors are developed by various companies. Demand for fetal monitoring devices is also increasing significantly to reduce intrapartum stillbirths. According to UNICEF, around 17 million intrapartum stillbirths occurred in the year 2018.
Portable monitoring devices are growing at a high rate because of benefits such as reduced hospital visits, increased adoption for home care treatment post-surgery, ease of handling, easy sanitization, and close mother-child interactions. Portable Monitoring Devices account for more than 60% of the market share and are estimated to grow at a CAGR of 6.87%. Envitec and Philips are manufacturing portable fetal and neonatal monitoring devices which are wireless and help in measuring oxygen.
Geographical Analysis
Geographically, the global fetal and neonatal monitoring devices market is divided into North America, Europe, South America, Asia-Pacific, the Middle East, and Africa.
North America is expected to dominate the market with the largest share of more than 40% followed by Europe with more than 25%. Major reasons include increasing government support for enhanced maternal facilities and rising company investments for the development of new products. In the US, the Newborn Intensive Care Unit (NICU) at Brigham and Women’s Hospital (BWH) has a 60-bed Level III newborn intensive care unit that provides complex multidisciplinary care to more than 3,000 babies each year.
Neonatal equipment has increasing demand in the countries of Asia-Pacific, as birth rates in these countries are higher, according to United Nations, 60% of the global population lives in Asia, as a result, sales of the equipment are expected to flourish at a rapid rate. Asia-Pacific is expected to grow at a CAGR of 10.52% over the period of forecast. According to WHO, 2018, most neonatal deaths occurred in Asia, which accounted for 47% of the total global neonatal deaths, given the high mortality rate in the South-central Asia sub-region.
Competitive Analysis
Some of the major key players are Becton, Dickinson and Company, FUJIFILM SonoSite, Inc., Medtronic, Drägerwerk AG & Co. KGAA, Cooper Surgical, Inc., CareFusion Corporation, Getinge AB, Natus Medical Incorporated, GE Healthcare, and Siemens Healthcare GMBH.
The global fetal and neonatal monitoring devices market is majorly dominated by five companies. BD, Drager, Fisher and Paykel, GE Healthcare, and Philips Healthcare constituted more than 70% of the market in 2018 out of which more than 50% is under BD, Drager, and Fisher and Paykel. Many players in the market are applying multiple strategies such as – mergers, acquisitions, partnerships, and launching new products to increase their global presence.
In September 2018, Koninklijke Philips N.V. announced that they had received a CE mark for its Avalon beltless system which is used for continuous fetal & maternal monitoring.
In March 2018, Incereb Ltd received an investment of €50,000, which is expected to expand the markets and provide solutions and services to the US as well.
In February 2018, GE Healthcare launched Versana Essential, a new ultrasound system.